Cellectar Biosciences(CLRB)
FLORHAM PARK, NJ
BiotechnologyFocus: Small Molecules
Cellectar Biosciences is a life sciences company focused on Small Molecules.
OncologyInfectious DiseasesUnknown
Funding Stage
PUBLIC
Open Jobs
1
Pipeline & Clinical Trials
Clinical Trials (1)
NCT01662284Study of 124I-NM404 in Advanced Solid Malignancies
N/ACLR 131
Head and Neck CancerClinical Trials (1)
NCT04105543CLR 131 Combined With Radiation for Head and Neck Cancer
Phase 1I-131-CLR1404
Multiple MyelomaClinical Trials (1)
NCT02278315Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma
Phase 1CLR 131
Pediatric Solid TumorClinical Trials (1)
NCT03478462Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma
Phase 1NOV-205
Hepatitis CClinical Trials (1)
NCT00372983Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy
Phase 1I-131-CLR1404
CancerClinical Trials (1)
NCT01495663Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned
Phase 1CLR 131
High-Grade GliomaClinical Trials (1)
NCT05610891Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG
Phase 1I124-NM404
Non Small Cell Lung CancerClinical Trials (1)
NCT00582283NM404 as an Imaging Agent in Patients With NSCLC
Phase 1I-131-CLR1404
Solid TumorsClinical Trials (1)
NCT00925275Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors
Phase 1Iopofosine I 131
Breast CancerClinical Trials (1)
NCT07311993Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
Phase 1I-131-CLR1404 Injection
GliomaClinical Trials (1)
NCT01778088Open-Label Study of I-131-CLR1404 in Subjects With Recurrent Glioma
Phase 2NOV-205
Hepatitis CClinical Trials (1)
NCT01058512A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy
Phase 2Iopofosine I 131 single dose
Waldenstrom MacroglobulinemiaClinical Trials (1)
NCT02952508Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia
Phase 2NOV-002
LeukemiaClinical Trials (1)
NCT00960726NOV-002 in Myelodysplastic Syndrome (MDS)
Phase 2NOV-002
Ovarian CancerClinical Trials (1)
NCT00345540Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer
Phase 2I-124-CLR1404
GlioblastomaClinical Trials (1)
NCT01898273Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
Phase 2Paclitaxel
Non Small Cell Lung CancerClinical Trials (1)
NCT00347412Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer
Phase 3Open Jobs (1)
Interview Prep Quick Facts
Portfolio: 17 clinical trials
SEC Filings: 2 available
Open Roles: 1 active job